J.P. Morgan Private Wealth Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,156
| Closed | -$294K | – | 1949 |
|
|
2022
Q2 | $294K | Sell |
10,156
-38,315
| -79% | -$1.11M | ﹤0.01% | 1657 |
|
|
2022
Q1 | $1.67M | Sell |
48,471
-3,284
| -6% | -$113K | ﹤0.01% | 974 |
|
|
2021
Q4 | $2.27M | Buy |
51,755
+2,585
| +5% | +$113K | ﹤0.01% | 860 |
|
|
2021
Q3 | $2.49M | Hold |
49,170
| – | – | 0.01% | 814 |
|
|
2021
Q2 | $2.56M | Buy |
49,170
+3,095
| +7% | +$161K | 0.01% | 788 |
|
|
2021
Q1 | $2.11M | Sell |
46,075
-3,095
| -6% | -$141K | 0.01% | 747 |
|
|
2020
Q4 | $2.26M | Buy |
49,170
+8,920
| +22% | +$410K | 0.01% | 684 |
|
|
2020
Q3 | $1.57M | Hold |
40,250
| – | – | 0.01% | 722 |
|
|
2020
Q2 | $1.53M | Hold |
40,250
| – | – | 0.01% | 660 |
|
|
2020
Q1 | $1.08M | Buy |
+40,250
| New | +$1.08M | 0.01% | 686 |
|